SEC Form 4 · accession 0001574774-18-000044
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Capper
Officer — President & CEO · Director
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 11, 2018 | M | 54,921 | $6.56 | A | 233,276 | D | |
| Common StockF2 | Jun 11, 2018 | S | 54,921 | $43.45 | D | 178,355 | D | |
| Common Stock | Jun 12, 2018 | M | 79,292 | $6.56 | A | 257,647 | D | |
| Common StockF3 | Jun 12, 2018 | S | 79,292 | $43.88 | D | 178,355 | D | |
| Common Stock | Jun 13, 2018 | M | 65,787 | $6.56 | A | 244,142 | D | |
| Common StockF4 | Jun 13, 2018 | S | 65,787 | $44.18 | D | 178,355 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $6.56 | Jun 11, 2018 | M | 54,921 | D | — | Jun 15, 2020 | Common Stock | 54,921 | 445,079 | D |
| Stock Options (Right to Buy)F5 | $6.56 | Jun 12, 2018 | M | 79,292 | D | — | Jun 15, 2020 | Common Stock | 79,292 | 365,787 | D |
| Stock Options (Right to Buy)F5 | $6.56 | Jun 13, 2018 | M | 65,787 | D | — | Jun 15, 2020 | Common Stock | 65,787 | 300,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $43.00 to $44.40, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3, and 4 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $43.20 to $44.50, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $43.50 to $44.43, inclusive.
- F5The stock options vested in four equal annual installments which began on June 15, 2011. The options were fully exercisable as of June 15, 2014.